Search Orphan Drug Designations and Approvals
-
Generic Name: | 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine |
---|---|
Date Designated: | 01/14/2020 |
Orphan Designation: | Treatment of sarcoidosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Molecure S.A. (previously OncoArendi S.A.) 101 Zwirki i Wigury street, Warsaw 02-089 Poland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-